hsa-mir-372: Hsa-mir-372 is a microRNA that has been found to play a role in various biological processes and diseases [PMC6892182]. It has been identified as an independent prognostic factor in ceRNA networks, interacting with multiple genes and miRNAs [PMC7249743]. Hsa-mir-372 has also been implicated in the development of hepatocellular carcinoma [PMC7271455]. In the MAPK pathway, LINC01010 has been shown to potentially inhibit the function of hsa-mir-372 [PMC8487518]. Hsa-mir-372, along with hsa-mir-20 and hsa-mir-10b, have been identified as having high degrees of interaction with real hub genes [PMC8739919]. High expression of hsa-mir-372 has been associated with poor prognosis in certain diseases [PMC5461634]. Hsa-miR-519a, hsa-miR-517a, and other miRNAs that target apoptosis-related genes have been implicated in the regulation of p53-signaling and apoptosis in recurrent miscarriage [PMC4829624]. Hsa-miR-191 has been detected abundantly in medium containing aneuploid embryos during embryonal development [PMC9425991]. In periodontitis tissue, hsa-mir-372 was found to be downregulated [PMC7606899]. The expression of hsa-miR-371,2,3 cluster members including hsa-mir-372 was also observed to be altered in certain diseases [PMC5399401].